OA
Oak Associates Portfolio holdings
AUM
$1.53B
1-Year Return
20.93%
This Quarter Return
+13.02%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.44B
AUM Growth
+$120M
(+9.1%)
Cap. Flow
-$30.9M
Cap. Flow
% of AUM
-2.14%
Top 10 Holdings %
Top 10 Hldgs %
46.5%
Holding
136
New
5
Increased
13
Reduced
35
Closed
2
Top Buys
| 1 |
Danaher
DHR
|
$1.98M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
$1.42M |
| 3 |
Incyte
INCY
|
$1.11M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$699K |
| 5 |
InMode
INMD
|
$442K |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$10.6M |
| 2 |
Amazon
AMZN
|
$9.24M |
| 3 |
Meta Platforms (Facebook)
META
|
$5.12M |
| 4 |
SolarEdge
SEDG
|
$2.34M |
| 5 |
Adtalem Global Education
ATGE
|
$1.1M |
Sector Composition
| 1 | Technology | 45.52% |
| 2 | Communication Services | 15.06% |
| 3 | Healthcare | 14.04% |
| 4 | Consumer Discretionary | 11.21% |
| 5 | Financials | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cigna
CI
$81.5B
| $16.3M | 1.13% |
44,801
| – | – |
|
27
Mastercard
MA
$528B
| $15.8M | 1.1% |
32,885
| – | – |
|
28
Novartis
NVS
$251B
| $14.7M | 1.02% |
152,158
-675
| -0.4% | -$65.3K |
|
29
Global Payments
GPN
$21.3B
| $13.9M | 0.96% |
103,662
+2
| +0% | +$267 |
|
30
Labcorp
LH
$23.2B
| $13.8M | 0.96% |
63,316
-1,302
| -2% | -$284K |
|
31
Alcon
ALC
$39.6B
| $13.6M | 0.94% |
163,428
-685
| -0.4% | -$57.1K |
|
32
McKesson
MCK
$85.5B
| $13M | 0.9% |
24,147
-300
| -1% | -$161K |
|
33
Qorvo
QRVO
$8.61B
| $11.5M | 0.8% |
100,007
| – | – |
|
34
Zimmer Biomet
ZBH
$20.9B
| $11.4M | 0.79% |
86,273
-490
| -0.6% | -$64.7K |
|
35
Amdocs
DOX
$9.46B
| $11.3M | 0.78% |
125,137
| – | – |
|
36
Microchip Technology
MCHP
$35.6B
| $11.1M | 0.77% |
123,349
| – | – |
|
37
Cognizant
CTSH
$35.1B
| $10.8M | 0.75% |
146,863
-907
| -0.6% | -$66.5K |
|
38
Amphenol
APH
$135B
| $10.7M | 0.74% |
186,224
| – | – |
|
39
Check Point Software Technologies
CHKP
$20.7B
| $9.68M | 0.67% |
59,008
| – | – |
|
40
Regeneron Pharmaceuticals
REGN
$60.8B
| $9.46M | 0.66% |
9,826
| – | – |
|
41
Pfizer
PFE
$141B
| $8.31M | 0.58% |
299,470
| – | – |
|
42
Lockheed Martin
LMT
$108B
| $7.92M | 0.55% |
17,401
| – | – |
|
43
Intel
INTC
$107B
| $7.88M | 0.55% |
178,476
+6,809
| +4% | +$301K |
|
44
Assurant
AIZ
$10.7B
| $7.83M | 0.54% |
41,603
| – | – |
|
45
Bank of New York Mellon
BK
$73.1B
| $6.31M | 0.44% |
109,549
+1
| +0% | +$58 |
|
46
Gilead Sciences
GILD
$143B
| $6.12M | 0.42% |
83,583
-692
| -0.8% | -$50.7K |
|
47
Salesforce
CRM
$239B
| $5.48M | 0.38% |
18,210
| – | – |
|
48
Applied Industrial Technologies
AIT
$10B
| $5.01M | 0.35% |
25,372
| – | – |
|
49
State Street
STT
$32B
| $4.54M | 0.31% |
58,741
-682
| -1% | -$52.7K |
|
50
Paychex
PAYX
$48.7B
| $4.43M | 0.31% |
36,115
-5
| -0% | -$614 |
|